Regeneron Pharmaceuticals, Inc. (REGN)
828.72
-5.32
(-0.64%)
USD |
NASDAQ |
Aug 24, 16:00
834.55
+5.83
(+0.70%)
After-Hours: 20:00
Regeneron Pharmaceuticals Total Assets (Quarterly) : 41.73B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.73B |
| March 31, 2026 | 40.87B |
| December 31, 2025 | 40.56B |
| September 30, 2025 | 40.17B |
| June 30, 2025 | 38.22B |
| March 31, 2025 | 37.55B |
| December 31, 2024 | 37.85B |
| September 30, 2024 | 37.44B |
| June 30, 2024 | 36.09B |
| March 31, 2024 | 34.37B |
| December 31, 2023 | 33.13B |
| September 30, 2023 | 32.16B |
| June 30, 2023 | 30.66B |
| March 31, 2023 | 30.06B |
| December 31, 2022 | 29.27B |
| September 30, 2022 | 27.68B |
| June 30, 2022 | 27.21B |
| March 31, 2022 | 26.35B |
| December 31, 2021 | 25.43B |
| September 30, 2021 | 23.67B |
| June 30, 2021 | 21.49B |
| March 31, 2021 | 17.77B |
| December 31, 2020 | 17.16B |
| September 30, 2020 | 16.08B |
| June 30, 2020 | 14.43B |
| Date | Value |
|---|---|
| March 31, 2020 | 15.76B |
| December 31, 2019 | 14.81B |
| September 30, 2019 | 13.94B |
| June 30, 2019 | 13.17B |
| March 31, 2019 | 12.85B |
| December 31, 2018 | 11.73B |
| September 30, 2018 | 10.81B |
| June 30, 2018 | 9.952B |
| March 31, 2018 | 9.373B |
| December 31, 2017 | 8.812B |
| September 30, 2017 | 8.701B |
| June 30, 2017 | 8.106B |
| March 31, 2017 | 7.817B |
| December 31, 2016 | 6.983B |
| September 30, 2016 | 6.828B |
| June 30, 2016 | 6.205B |
| March 31, 2016 | 5.904B |
| December 31, 2015 | 5.630B |
| September 30, 2015 | 5.183B |
| June 30, 2015 | 4.527B |
| March 31, 2015 | 4.199B |
| December 31, 2014 | 3.872B |
| September 30, 2014 | 3.739B |
| June 30, 2014 | 3.456B |
| March 31, 2014 | 3.260B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Gilead Sciences, Inc. | 49.36B |
| AbbVie, Inc. | 135.12B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
| Amgen, Inc. | 95.64B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.02B |
| Shareholders Equity (Quarterly) | 31.71B |
| Debt to Equity Ratio | 0.0854 |
| Current Ratio | 3.335 |
| Net Debt Paydown Yield | -0.00% |